Mitiglinide is an oral anti-diabetic medication used to treat type 2 diabetes mellitus. It helps control blood sugar levels by stimulating rapid insulin release from the pancreas, especially after meals. Mitiglinide is typically used in combination with other antidiabetic drugs like metformin. It is grouped under the following drug class(es): Hypoglycemics. Its therapeutic use is listed as antidiabetic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include mitiglinida and mitiglinidum. Its PubChem CID is 121891.
Mitiglinide
| CAS No | 145375-43-5 |
|---|---|
| Molecular Formula | C19H25NO3 |
| Molecular Weight | 315.40 g/mol |
| Synonyms | (2S)-4-[(3aS,7aR)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]-2-benzyl-4-oxobutanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Mitiglinide is an oral anti-diabetic medication used to treat type 2 diabetes mellitus. It helps control blood sugar levels by stimulating rapid insulin release from the pancreas, especially after meals.
The listed CAS number is 145375-43-5.
The listed molecular formula is C19H25NO3.
The listed molecular weight is 315.40 g/mol.
(2S)-4-[(3aS,7aR)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]-2-benzyl-4-oxobutanoic acid.
The source lists mitiglinida and mitiglinidum.